FDA takes steps to authorize some naloxone products for over-the-counter sale

  • 📰 YahooNews
  • ⏱ Reading Time:
  • 74 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 33%
  • Publisher: 59%

United States Headlines News

United States Latest News,United States Headlines

The U.S. Food and Drug Administration has issued a notice that could help increase access to overdose-reversing naloxone drug products without the need for a prescription, paving the way to make more of them available for over-the-counter use.

Naloxone is a medication that blocks opiate receptors in the nervous system and rapidly reverses opioid overdoses when given to an overdosing person in a timely manner. In 2021, more than 107,000 Americans died of an overdose,from the Centers for Disease Control and Prevention. About 75% of those overdoses were related to opioids, including heroin and fentanyl.

"Today's action supports our efforts to combat the opioid overdose crisis by helping expand access to naloxone," said FDA Commissioner Robert M. Califf, M.D., in a Tuesday ."The agency will keep overdose prevention and reduction in substance use disorders as a key priority and area of intense strategic focus for action as rapidly as possible."Naloxone is available in all 50 states, and, ,"many states have laws that allow pharmacists to dispense naloxone without a prescription." Community-based programs and syringe exchange services may also distribute naloxone.

The notice issued by the FDA, known as a Federal Register notice, aims to change some naloxone drug products from prescription status to nonprescription status, in addition to developing and approving new products. The notice includes a preliminary assessment stating that certain naloxone products, both nasal and injectable, may be approvable as"safe and effective for nonprescription use.

While the assessment is a step forward, it is not a final determination that certain naloxone products are safe and effective for nonprescription use, and it does not mandate that naloxone products immediately be made available for over-the-counter purchase. The final decision will be made by the FDA, based on additional data that would usually be submitted to the agency in an application for a proposed nonprescription naloxone product.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Give more money to the pharmacy company that created the addict. These companies getting paid on both sides. Capitalism

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 380. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

16 Obstacles People With Disabilities Will Continue To Face If Able-Bodied People Continue To Be IgnorantOne in four adults in the United States live with a disability. some of these are totally accurate but some people really need to keep in mind that invisible disability’s exist *lives
Source: BuzzFeed - 🏆 730. / 51 Read more »

FDA Developing Plan to Guard Against Bacteria Outbreaks in Baby FormulaThe Food and Drug Administration is developing a plan to guard against cronobacter bacteria outbreaks in baby formula Yeah I trust the FDA about as far I can throw it
Source: WSJ - 🏆 98. / 63 Read more »

AI For Diabetic Retinopathy Screening Gets U.S. FDA ApprovalThe AEYE Health AI model performs better than human experts, diagnosing diabetes from otherwise healthy retinas.
Source: ForbesTech - 🏆 318. / 59 Read more »

FDA warns of rise in reports of child poisonings linked to cough medicineReports to poison control centers about children ingesting a prescription drug called benzonatate rose from 2010 through 2018. Thanks Biden 😡 (IM JOKING BTW) What the study doesn't mention is that they identify as adults so it's alright Sounds like the parents need to do a better job keeping it away from their kids
Source: NBCNewsHealth - 🏆 707. / 51 Read more »

U.S. FDA staff flags unclear benefits of Ardelyx's kidney disease drugU.S. Food and Drug Administration staff reviewers on Monday raised concerns over unclear benefits of Ardelyx Inc's drug for kidney disease patients, but the company's shares rose 20% on expectations over a possible approval. Now do Covid vaccines. I'll wait. Ok all the walls 👏🏾👏🏾👏🏾👏🏾👏🏾
Source: Reuters - 🏆 2. / 97 Read more »

Google agrees to $392 million settlement with 40 states over location tracking practices | CNN BusinessGoogle has agreed to a record $391.5 million settlement with 40 states for allegedly misleading consumers over its location tracking practices, a coalition of attorneys general announced Monday. Made how much selling the data? Just curious who gets the money? Oh state governments do? Sounds like extortion. Google dünya kullanıyor, cezayı ülkelere dağıtması lazım! Adalet tam olmalı!
Source: CNN - 🏆 4. / 95 Read more »